Related Experiment Video
Updated: Jul 2, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature
Nasifa Nur1, Cameron Lang2, Juanita K Hodax1
1Division of Pediatric Endocrinology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Insights
Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder causing severe salt wasting in infants. Early diagnosis and sodium supplementation are crucial for managing this condition.
Area of Science:
- Genetics
- Pediatrics
- Endocrinology
Background:
- Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder.
- It results from mutations in epithelial sodium channel subunits.
- Manifestations include salt wasting, hyperkalemia, and metabolic acidosis in infants.
Abstract:
Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder resulting from mutations in the subunits of the epithelial sodium channel that manifests as severe salt wasting, hyperkalemia, and metabolic acidosis in infancy. In this article we report a patient with systemic PHA type I presenting with severe dehydration due to salt wasting at 6 days of life. She was found to have a known mutation in the SCNN1A gene and subsequently required treatment with sodium supplementation. We also review the clinical presentation, differential diagnosis, and treatment of systemic PHA type I and summarize data from 27 cases with follow-up data.
Related Concept Videos
Hormonal Regulation
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension II: Pathophysiology
Cushing Syndrome II: Pathophysiology

